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 Purpose 
The purpose of this evidence-based project is to 
answer the following question: In pediatric patients 
with Major Depressive Disorder (MDD), how does 
combination treatment with a Selective Serotonin 
Reuptake Inhibitor (SSRI) and cognitive behavior 
therapy (CBT) affect symptoms of depression, when 
compared with using only an SSRI? 
Background 
• Pediatric MDD 11.7%,6 increasing >50% by 2020, will 
be in top 5 causes of mortality and morbidity in 
children.4 
• Common symptoms: chronic pain, headaches, risky 
sexual behaviors, STIs, poor eating/sleeping; 
Increased health costs; poor performance in school 
and relationships.1,2,7 
• Suicide 3rd leading cause of death for teens.6 
• Many PCPs uncomfortable treating pediatric patients, 
especially very young (<12 years old).3,6 Only 1 in 5 
children with MDD receive appropriate treatment.7  
• Clinical practice guidelines lacking in pediatric 
population; metabolism, response to medications in 
the brain & developmental processes not well 
understood and are different than adults;  treatment 
has been very conservative.6 
 
Evidence Synthesis 
• Depression scores on standardized tests 
decreased with combo therapy – not statistically 
significant, however. 
• Suicidality decreased significantly in both 
groups, showing positive effect of SSRI with or 
without CBT. 
• Time to remission of symptoms not significantly 
less with combo therapy, however rate of 
relapse was much lower, showing a clinical 
significance in adding CBT to treatment.  
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Proposed Evaluation 
• Follow up 4wks, 6mo, and 1yr – 
instability/adherence issues require closer 
management.  
• Standardized testing to evaluate results include:  
Beck’s Depression Inventory (BDI) - self-
reported symptoms: dysphoria, anhedonia, 
suicidality, sleep dysfunction, cognitive 
function, and appetite changes.2  
Children’s Global Assessment Scale – 
Revised (CGAS-R) - Provider-reported 
symptoms 5  
Child-Behavior Checklist (CBCL) – Parent 
checklist on behavior, problem-solving, and 
somatic symptoms.1 
 
References 
Multiple databases searched: CINAHL, MEDLINE, and 
a general medical database search. Keywords used 
include “pediatric,” “depression,” “MDD,” “SSRI,” 
“CBI,” “non-pharmacological,” “psychotherapy,” and 
“nutrition.” Four studies were included with level of 
evidence and validity generally average to high 
quality.  
Translation to Practice 
• Education and counseling on depression.   
• Refer to social worker or therapist if needed. 
Assess for safety, potential for self-harm, follow 
up in 2-4 months.  
• Start low dose SSRI. Titrate up to min effective 
dose & continue for 6-12 months after remission 
of symptoms..3  
• CBT: provide education & treatment plan for 
MDD, teach relaxation, coping  & problem-
solving, encourage goal-setting, & increase 
engagement and cooperation, decrease of 
symptoms.7  
• Considerations – children and teens can be 
especially difficult to treat due to lack of 
knowledge and understanding of importance of 
these treatments, adherence issues. Obtain 
parental support for CBT & assist with 
accessibility. Arrange so social impact as low as 
possible for the patient – not during school time 
or interfering with social activities. 
 
 
Conclusion 
• CBT should be considered as an effective 
treatment in all forms and severities of 
depression.  
• SSRI treatment for moderate-severe depression.  
• Regular evaluation of efficacy of treatments and 
assessment for further symptoms is critical to 
ensure remission and prevent relapse.  
